The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $66.05

Today's change+0.75 +1.15%
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.
 

U.S. Physical Therapy Inc

NYSE: USPH
Last

(U.S.) $66.05

Today's change+0.75 +1.15%
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.

U.S. Physical Therapy Inc Hits New 50-day High

U.S. Physical Therapy Inc closed up Friday by (U.S.)$0.75 or 1.15% to (U.S.)$66.05 and setting a new 50-day high. Over the last five days, shares have gained 4.10%, but are down 5.91% for the last year to date. Shares have underperformed the S&P 500 by 14.50% during the last year.

Key company metrics

  • Open(U.S.) $65.70
  • Previous close(U.S.) $65.30
  • High(U.S.) $66.50
  • Low(U.S.) $65.68
  • Bid / Ask-- / --
  • YTD % change-5.91%
  • Volume68,664
  • Average volume (10-day)73,402
  • Average volume (1-month)62,431
  • Average volume (3-month)61,118
  • 52-week range(U.S.) $51.96 to (U.S.) $78.00
  • Beta1.05
  • Trailing P/E46.24×
  • P/E 1 year forward31.23×
  • Forward PEG3.12×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield1.21%
  • Trailing EPS(U.S.) $1.43
Updated October 20 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.50%

Based on its net profit margin of 5.50%, U.S. Physical Therapy Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.25%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue104989188
Total other revenue--------
Total revenue104989188
Gross profit25211920
Total cost of revenue80777269
Total operating expense89858076
Selling / general / administrative9988
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income16121112
Interest income (expense), net non-operating-1000
Gain (loss) on sale of assets--------
Other--------
Income before tax98012
Income after tax6618
Income tax, total3204
Net income5526
Total adjustments to net income--------
Net income before extra. items5526
Minority interest-1-12-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5526
Inc. avail. to common incl. extra. items5526
Diluted net income5526
Dilution adjustment--------
Diluted weighted average shares13131313
Diluted EPS excluding extraordinary itemsvalue per share0.390.380.190.46
Dividends per sharevalue per share0.200.200.170.17
Diluted normalized EPSvalue per share0.390.380.200.46